Skip to content

Seroprevalence

Genomics Division, ITER edited this page Aug 12, 2020 · 14 revisions

COVID-19

A public repository of scientific and media resources of SARS-CoV-2 related COVID-19 maintained by ITER.


Seroprevalence

Section to show information on Seroprevalence and related on going studies.

A case of a readmitted patient who recovered from COVID-19 in Chengdu, China

A serological assay to detect SARS-CoV-2 seroconversion in humans

A serological assay to detect SARS-CoV-2 seroconversion in humans

A Statistical Analysis Of CoV-19 Positive Test Frequency Data Indicates A Need For Greater Attention To CoV-19 Test Quality And Pre-Wuhan Cov-19 Prevalence

Considering how biological sex impacts immune responses and COVID-19 outcomes

Coronavirus: los primeros datos de seroprevalencia estiman que un 5% de la población ha estado contagiada, con variabilidad según provincias | INFORME

COVID-19 and Postinfection Immunity. Limited Evidence, Many Remaining Questions

COVID-19 Antibody Seroprevalence in Santa Clara County, California

Daily viral kinetics and innate and adaptive immune responses assessment in COVID-19: a case series

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery

Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals

Dissecting antibody-mediated protection against SARS-CoV-2

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Estimating COVID-19 Antibody Seroprevalence in Santa Clara County, California. A re-analysis of Bendavid et al.

Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors

Estimating population immunity without serological testing

Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region

Humoral Response Dynamics Following Infection with SARS-CoV-2

Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection

Immune evasion via SARS-CoV-2 ORF8 protein?

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Long-Term Persistence of IgG Antibodies in SARS-CoV Infected Healthcare Workers

Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence Testing in Idaho

Phenotype of SARS-CoV-2-specific T-cells in COVID-19 patients with acute respiratory distress syndrome

Pre-existing immunity to SARS-CoV-2: the knowns and unknowns

Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells

Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

SARS-CoV-2 seroprevalence in COVID-19 hotspots

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Test performance evaluation of SARS-CoV-2 serological assays

The potential danger of suboptimal antibody responses in COVID-19

Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment

Transient IgA, steady IgG?

Viral RNA level, serum antibody responses, and transmission risk in discharged COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study

Clone this wiki locally